Abstract
Metastatic cancer is the most common malignant tumor affecting bone and is accompanied by significant clinical morbidity, including pain, osteolysis, pathological fracture, spinal compression syndromes and hypercalcemia. Bone destruction is a marked clinical feature and the major source of morbidity associated with bone metastases. Most of these clinical features can be related to structural changes in bone that are caused by effects of the tumor on normal processes of bone remodeling.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Coleman RE. Skeletal complications of malignancy. Cancer, 80: 1588–1594, 1997.
Vigorita VJ. Metastatic bone disease, pp. 472–489. In: Orthopaedic Pathology. V. H. Vigorita eds., Philadelphia, New York, Baltimore: Lippincott William and Wilkins, 1999.
Vinholes J, Coleman R, Eastell R. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev, 22: 289–331, 1996.
Parfitt AM. Bone remodeling, normal and abnormal: a biological basis for the understanding of cancer-related bone disease and its treatment. Can J Oncol, 5 (Suppl. l): 1–10, 1995.
Hiraga T, Tanaka S, Ikegame M, Koizumi M, Iguchi H, Nakajima T, Ozawa H. Morphology of bone metastasis. Eur J Cancer, 34: 230–239, 1998.
Mundy GR. Mechanism of bone metastasis. Cancer, 80 (Suppl 8): 1546–1556, 1997.
Galasko CSB. Mechanism of lytic and blastic metastatic disease of bone. Clin Orthop, 169: 20–27, 1982.
Kulenkampff HA, Dreyer T, Kersjes W, Delling G. Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas. Virchows Arch. [Pathol Anat], 409: 817–828, 1986.
Kleerekoper M, Villanueva AR, Stanciu J, Sudhaker Rao D, Parfitt AM. The role of three-dimensional trabecular microstructure in the pathogenesis of vertebral compression fractures. Calcif Tissue Int, 37: 594–597, 1985.
Tsuchida T, Sato K, Miyakoshi N, Abe T, Kudo T, Kasukawa Y, Suzuki K. Histomorphometric evaluation of the recovering effect of human parathyroid hormone (1–34) on bone structure and turnover in streptozotocin-induced diabetic rats. Calcif Tissue Int, 66: 229–233, 2000.
Bross P, Reynders P, Vanderschot P. Surgical treatment of the metastatic fracture of the femur improves quality of life. Acta Orthop Belg, 59 (Suppl 1): 52–56, 1993.
Vukmirovic-Popovic S, Colterjohn N, Lhotak S, Duivenvoorden WC, Orr FW, Singh G. Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma. Bone, 31: 529–535, 2002.
Coindre JM, Mage P, Bui BN, Goussot JF, De Mascarel A, Trojani M. Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results. Presse Med, 14: 1823–1827, 1985.
Hiraga T, Mundy GR, Yoneda T. Bone metastases-morphology, pp. 65–74. In: Cancer and the Skeleton. R. D. Rubens and G. R. Mundy eds, London: Martin Dunitz Ltd, 2000.
Yamaguchi T, Tamai K, Yamato M, Honma K, Ueda Y, Saotome K. Intertrabecular pattern of tumours metastatic to bone. Cancer, 78: 1388–1394, 1996.
Fornasier VL, Horne JG. Metastases to the vertebral column. Cancer, 36: 590–594, 1975.
McCarthy EF, Frassica FJ. Metastatic carcinoma in bone, pp. 175–183. In: Pathology of bone and joint disorders with Clinical and Radiographic Correlation. McCarthy EF, Frassica FJ, eds, Philadelhia, PA: W. B. Saunders, 1998.
Clarke NW, McClure J, George NJR. Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol, 68: 74–80, 1991.
Arguello FB, Baggs RB, Frantz CN. A murine model of experimental metastasis to bone and bone marrow. Cancer Res, 48: 6876–6881, 1988.
Yoneda T. Arterial microvascularization and breast cancer colonization in bone. Histol Histopathol, 12: 1145–1149, 1997.
Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Action of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer, 88: 2979–2988, 2000.
Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res, 55: 3551–3557, 1995.
Sasaki A, Kitamura K, Alcalde RE, Tanaka T, Suzuki A, Etoh Y, Matsumura T. Effect of a newly developed bisphosphonate, YH529, on osteolytic bone metastases in nude mice. Int J Cancer, 77: 279–285, 1998.
Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res, 59: 1987–1993, 1999.
Nemeth JE, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML. Matrix metalloproteinase activity, bone matrix turnover, and tumour cell proliferation in prostate cancer bone metastasis. J Natl Cancer Inst, 94: 17–25, 2002.
Rabbani SA, Harakidas P, Davidson DJ, Henkin J, Mazar AP. Prevention of prostate-cancer metastasis in vivo by novel synthetic inhibitor of urokinase-type plasminogene activator (uPA). Int J Cancer, 63: 840–845, 1995.
Sanchez-Sweatman OH, Lee J, Orr FW, Singh G. Direct osteolysis induced by metastatic murine melanoma cells: of matrix metalloproteinases. Eur J Cancer, 33: 918–925, 1997.
Duivenvoorden WC, Vukmirovic Popovic S, Lhotak S, Seidlitz E, Hirte H W, Tozer RG, Singh G. Doxycycline decreases tumour burden in a bone metastasis model of human breast cancer. Cancer Res, 62: 1588–1591, 2002.
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Min Res, 2: 595–610, 1987.
Parfitt AM. Stereological basis of bone histomorphometry: Theory of quantitative microscopy and reconstruction of the third dimension, pp. 61–64. In: Bone histomorphometry: techniques and interpretation. R. R. Recker eds., Florida: Boca Raton, CRC Press, 1982.
Parfitt AM, Mathews CH, Villanueva AR, Kleerekope, M, Frame BR. Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest, 72: 1396–1409, 1983.
Melish RWE, Ferguson-Pell, MW, Cochran GV, Lindsay R, Dempster DW. A new manual method for assessing two-dimensional cancellous bone structure: comparison between iliac crest and lumbar vertebra. J Bone Miner Res, 6: 689–696, 1991.
Carbonare LD, Arlot, ME, Chavassieux JP, Roux JP, Portero NR, Meunier PJ. Comparison of trabecular bone microarchitecture and remodeling in glucocorticoidinduced and postmenopausal osteoporosis. J Bone Miner Res, 16: 97–103, 2001.
Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M. Effect of intermittent administration of low dose human PTH (1–34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone, 21: 501–506, 1997.
Mundy GR, Guise TA. Pathophysiology of bone metastasis, pp. 43–64. In: Cancer and the Skeleton. Rubens RD, Mundy GR, eds, London: Martin Dunitz, 2000.
Galasko CSB. Mechanism of bone destruction in the development of skeletal metastases. Nature, 263: 507–508, 1976.
Taube T, Beneton MNC, McCloskey EV, Rogers S, Greaves M, Kanis JA. Abnormal bone remodeling in patients with myelomatosis and normal biochemical indices of bone resorption. Eur J Haematol, 49: 192–198, 1992.
Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA. Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: A histomorphometric study. Eur J Cancer, 29A /12: 1677–1681, 1993.
Taube T, Elomaa I, Blomqvist C, Beneton MNC, Kanis JA. Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone, 15: 161–166, 1994.
Eilon G, Mundy GR. Direct resorption of bone by human breast cancer cells in vitro. Nature, 276: 726–729, 1978.
Sanchez-Swetman OH, Orr FW, Singh G. Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases. Invasion Metastasis, 18: 297–305, 1998–1999.
Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJ, Beertsen W. Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J, 13: 1219–1230, 1999.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Vukmirovic-Popovic, S., Seidlitz, E., Orr, F.W., Singh, G. (2004). Comparative Morphometric Study on Bone Remodeling in Human Specimens and in Experimental Models of Metastatic Bone Disease. In: Singh, G., Orr, W. (eds) Bone Metastasis and Molecular Mechanisms. Cancer Metastasis — Biology and Treatment, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-2036-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4020-2036-0_3
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6563-6
Online ISBN: 978-1-4020-2036-0
eBook Packages: Springer Book Archive